Are we there ....., page-13

If you want some ECS positivity. Just look up Murray Sherbert and Green Gelato on Reddit. The UK medicinal cannabis thread is exceptionally fond of it, they look to have re-stocked in the past week or so. But the descriptions and reviews are near-all positive. When people say that their prescriber recommends an ECS product, you can’t complain. Alongside ECS not having to put in any of the laborious education of prescribers and advertising that comes with selling own brands.

And it seems although we market as a premium flower, people indicate that it’s around £5.5/g in a 30g pouch (from Curaleaf). Which is about £0.8 more than the cheapest on the market. Many others are selling around the £8-9 mark. So buyers are stating that ECS is a great ‘value’ product. Regardless, the product is out there, it’s high quality and being well received. Under the banner of Curaleaf none the less, likely one of, if the most reputable global brand (~$4.4b AUD market cap). If anyone is to acquire a $20m market cap sized grower to diversify their regional range, it’s them. If someone else like Bloomwell doesn’t do it first.

Again, I am so unbelievably bullish on ECS and we are well and truly present in the global market. Once people find a strain they find beneficial and therapeutic, they want to stay with it. Demand grows, ECS demand grows and so on, you know the story. I suspect the Amnesia Haze that we recently had TGA export approval will soon hit the shelves, potentially for Ilios Sante, which will give the exposure to the rapidly expanding German market. I am honestly not sure how ECS plans on being able to scale up quick enough. There are definitely worse positions to be in than having our product in too much demand.